Business
New Partnership Agreement in South Korea
New Partnership Agreement in South Korea.
About this update from Probiotix Health Plc
[{"type":"text","content":"\n\n28 March 2025\n \nProBiotix Health plc\n(\"ProBiotix\" or the \"Company\" or, together with its subsidiary, the \"Group\")\n \nNew Partnership Agreement in South Korea\n \nProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce a new long-term partnership agreement in South Korea.\n \nProBiotix has signed an exclusive commercial agreement with TopHealth, a leading South Korea based consumer products company, focused on promoting health and wellness. Under the terms of the partnership, ProBiotix has granted TopHealth the rights to sell finished consumer products direct to consumers in South Korea.\n \nThe agreement spans three areas of distribution: products marketed under the ProBiotix CholBiome® brand, YourBiotix private turnkey solutions to be sold to South Korea based brand owners and sales of product solutions under TopHealth's own consumer brand. The first phase of the cooperation will focus on the import and direct sale of CholBiome® X3 to consumers. Following this, local registration will be required for TopHealth to market its own brand Bifolacto using LPLDL in the product.\n \nPrivately owned, TopHealth develops scientifically backed, high quality health supplements with a particular focus in the area of probiotics. Since 2017, it has progressed its award winning Bifolacto brand from one product formulation within women's health, to become one of the top three fastest growing supplement brands in South Korea. TopHealth has a broad portfolio of produc...